0000899243-19-003848.txt : 20190215 0000899243-19-003848.hdr.sgml : 20190215 20190215163138 ACCESSION NUMBER: 0000899243-19-003848 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190213 FILED AS OF DATE: 20190215 DATE AS OF CHANGE: 20190215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gover Justin D. CENTRAL INDEX KEY: 0001754129 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35892 FILM NUMBER: 19611928 MAIL ADDRESS: STREET 1: SOVEREIGN HOUSE, VISION PARK, HISTON CITY: CAMBRIDGE STATE: X0 ZIP: CB24 9BZ ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GW PHARMACEUTICALS PLC CENTRAL INDEX KEY: 0001351288 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: SOVEREIGN HOUSE STREET 2: VISION PARK CITY: HISTON, CAMBRIDGE CB24 9BZ STATE: X0 ZIP: 00000 BUSINESS PHONE: 44 1223 266800 MAIL ADDRESS: STREET 1: SOVEREIGN HOUSE STREET 2: VISION PARK CITY: HISTON, CAMBRIDGE CB24 9BZ STATE: X0 ZIP: 00000 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-13 0 0001351288 GW PHARMACEUTICALS PLC GWPH 0001754129 Gover Justin D. SOVEREIGN HOUSE, VISION PARK, HISTON CAMBRIDGE X0 CB24 9BZ UNITED KINGDOM 1 1 0 0 Chief Executive Officer Ordinary Shares 2019-02-13 4 S 0 22620 12.50 D 370445 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 16, 2018. These ordinary shares are represented by American Depositary Shares of the Issuer ("ADS"). Each ADS represents twelve ordinary shares of the Issuer. The reporting person acquired these shares on December 20, 2018 in connection with an exercise of options that were due to expire on December 24, 2018. The price reported in Column 4 is price per ordinary share ($150.0 per ADS). /s/ Justin D. Gover 2019-02-15